Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIMERSEN vs CATEQUENTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIMERSEN vs CATEQUENTINIB: Safety Overview

Metric CASIMERSEN CATEQUENTINIB
Total FAERS Reports 767 324
Deaths Reported 7 44
Death Rate 0.9% 13.6%
Hospitalizations 87 115
Average Patient Age 14.0 yrs 57.2 yrs
% Female Patients 0.4% 38.7%
FDA Approval Date Feb 25, 2021 N/A
Manufacturer Sarepta Therapeutics, Inc. N/A
Marketing Status Prescription N/A